Feb 12, 2021 9:25 am EST VolitionRx Limited Announces Closing of $20 Million Underwritten Public Offering of Common Stock
Feb 10, 2021 9:18 am EST VolitionRx Limited Announces Pricing of $20 Million Underwritten Public Offering of Common Stock
Feb 9, 2021 4:01 pm EST VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock
Feb 2, 2021 7:45 am EST VolitionRx Provides a Business Update and Appoints Key Officers to Drive Commercialization Efforts
Jan 28, 2021 6:21 am EST National Taiwan University Hospital Presents Data on Nu.Q™ Assay Performance at the World Conference on Lung Cancer
